Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-02-07 @ 6:24 PM
Study NCT ID:
NCT05028504
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2021-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer
Sponsor:
Sichuan Cancer Hospital and Research Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gynecological Cancer | View |
Keywords: